BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21569259)

  • 1. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
    Rusina R; Kovacs GG; Fiala J; Hort J; Ridzoň P; Holmerová I; Ströbel T; Matěj R
    BMC Neurol; 2011 May; 11():50. PubMed ID: 21569259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease.
    Espay AJ; Spina S; Houghton DJ; Murrell JR; de Courten-Myers GM; Ghetti B; Litvan I
    J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):751-3. PubMed ID: 20587488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
    Storey K; Johanidesová S; Matěj R; Keller J; Rohan Z; Rusina R
    Neurocase; 2017 Feb; 23(1):5-11. PubMed ID: 27915581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss.
    Kobayashi Z; Tsuchiya K; Arai T; Yokota O; Yoshida M; Shimomura Y; Kondo H; Haga C; Asaoka T; Onaya M; Ishizu H; Akiyama H; Mizusawa H
    J Neurol Sci; 2010 Nov; 298(1-2):70-7. PubMed ID: 20810131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
    Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
    Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
    Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease.
    Takeda T; Seilhean D; Le Ber I; Millecamps S; Sazdovitch V; Kitagawa K; Uchihara T; Duyckaerts C
    J Neuropathol Exp Neurol; 2017 Sep; 76(9):800-812. PubMed ID: 28859337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy.
    Paviour DC; Lees AJ; Josephs KA; Ozawa T; Ganguly M; Strand C; Godbolt A; Howard RS; Revesz T; Holton JL
    Brain; 2004 Nov; 127(Pt 11):2441-51. PubMed ID: 15459024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FTLD/ALS as TDP-43 proteinopathies].
    Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
    Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
    J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI signatures of the frontotemporal lobar degeneration continuum.
    Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
    Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
    Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M
    Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
    Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
    Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.
    Cairns NJ; Neumann M; Bigio EH; Holm IE; Troost D; Hatanpaa KJ; Foong C; White CL; Schneider JA; Kretzschmar HA; Carter D; Taylor-Reinwald L; Paulsmeyer K; Strider J; Gitcho M; Goate AM; Morris JC; Mishra M; Kwong LK; Stieber A; Xu Y; Forman MS; Trojanowski JQ; Lee VM; Mackenzie IR
    Am J Pathol; 2007 Jul; 171(1):227-40. PubMed ID: 17591968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
    Geser F; Lee VM; Trojanowski JQ
    Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.